aterosklerozАтеросклерозAteroscleroz2078-256X2949-3633НИИТПМ-филиал ИЦиГ СО РАН10.52727/2078-256X-2025-21-2-204-213ateroskleroz-1120Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSАртериальная тромбоэмболия (ишемический инсульт, острая окклюзия периферических артерий) у больных со злокачественными заболеваниями: диагностика, профилактика, лечение. Обзор литературы. Часть 2Arterial thrombosis in patients with malignant diseases: definition, features, diagnostics, treatment. Literature review. Рart 2https://orcid.org/0009-0008-7674-9751КозловД. В.KozlovD. V.

Денис Владимирович Козлов, канд. мед. наук, врач - сердечно-сосудистый хирург

105187, г. Москва, ул. Фортунатовская, 1

Denis V. Kozlov, candidate of medical sciences, cardiovascular surgeon

1, Fortunatovskaya st., Moscow, 105187

https://orcid.org/0009-0000-9735-8073ЗагорулькоА. И.ZagorulkoA. I.

Алексей Иванович Загорулько, канд. мед. наук, зав. отделением рентгенохирургических методов диагностики и лечения №2; врач по рентгенэндоваскулярным диагностике и лечению; доцент кафедры кардиологии, рентгенэндоваскулярных и гибридных методов диагностики и лечения

117152, г. Москва, Загородное шоссе, 18а, стр. 7.

117198, г. Москва, ул. Миклухо-Маклая, 6

Alexey I. Zagorulko, candidate of medical sciences, head of the department of X-ray endovascular methods of diagnosis and treatment No. 2

 

https://orcid.org/0009-0008-7473-6471НистратовГ. П.NistratovG. P.

Григорий Павлович Нистратов, канд. мед. наук, врач по рентгенэндоваскулярным диагностике и лечению отделения рентгенохирургических методов диагностики и лечения № 2

117152, г. Москва, Загородное шоссе, 18а, стр. 7.

Grigory P. Nistratov, candidate of medical sciences, doctor at the department of X-ray endovascular methods of diagnosis and treatment No. 2

18a, build. 7, Zagorodnoye higw., Moscow, 117152

https://orcid.org/0009-0000-8486-3505РыковС. П.RykovS. P.

Станислав Павлович Рыков, врач по рентгенэндоваскулярным диагностике и лечению отделения рентгенохирургических методов диагностики и лечения № 2

117152, г. Москва, Загородное шоссе, 18а, стр. 7.

Stanislav P. Rykov, doctor at the department of X-ray endovascular methods of diagnosis and treatment No. 2

18a, build. 7, Zagorodnoye higw., Moscow, 117152

Государственное бюджетное учреждение здравоохранения города Москвы «Городская клиническая больница имени Ф.И. Иноземцева Департамента здравоохранения города Москвы» РоссияРоссияState Budgetary Healthcare Institution of the city of Moscow “F.I. Inozemtsev City Clinical Hospital of the Department of Health of the City of Moscow”Russian FederationОнкологический центр № 1 Государственного бюджетного учреждения здравоохранения города Москвы «Городская клиническая больница имени С.С. Юдина Департамента здравоохранения города Москвы»; Федеральное государственное автономное образовательное учреждение высшего образования «Российский университет дружбы народов имени Патриса Лумумбы»РоссияOncological Center No. 1 of the State Budgetary Healthcare Institution of the city of Moscow “S.S. Yudin City Clinical Hospital of the Department of Health of the City of Moscow”Russian FederationОнкологический центр № 1 Государственного бюджетного учреждения здравоохранения города Москвы «Городская клиническая больница имени С.С. Юдина Департамента здравоохранения города Москвы»РоссияOncological Center No. 1 of the State Budgetary Healthcare Institution of the city of Moscow “S.S. Yudin City Clinical Hospital of the Department of Health of the City of Moscow”Russian Federation202509072025212204213Copyright © Козлов Д.В., Загорулько А.И., Нистратов Г.П., Рыков С.П., 20252025Козлов Д.В., Загорулько А.И., Нистратов Г.П., Рыков С.П.Kozlov D.V., Zagorulko A.I., Nistratov G.P., Rykov S.P.This work is licensed under a Creative Commons Attribution 4.0 License.https://ateroskleroz.elpub.ru/jour/article/view/1120

Злокачественные новообразования (ЗНО) и противоопухолевая терапия увеличивают риск развития артериальной тромбоэмболии (АТЭ) (ишемического инсульта, острой артериальной окклюзии периферических артерий). В статье представлены частота развития АТЭ у данных пациентов, факторы риска развития АТЭ в зависимости от видов ЗНО, а также особенности профилактики и лечения АТЭ-осложнений у больных с ЗНО.

Malignant neoplasms and antitumor therapy increase the risk of arterial thromboembolism (ischemic stroke, acute arterial occlusion of peripheral arteries). The article presents the incidence of ATE in these patients, the risk factors for the development of ATE depending on the type of caner, as well as the prevention and treatment of ATE complications in patients with cancer.

артериальная тромбоэмболияострая артериальная окклюзияартериальный тромбоззаболевание периферических артерийопухольэмболияракновообразованиеишемиязлокачественное новообразованиеинсультarterial thromboembolismarterial thromboembolicacute arterial occlusionarterial thrombosisperipheral artery diseasetumorembolismcancerneoplasmischemiamalignancystrokeReferencesCostamagna G., Hottinger A., Milionis H., Lambrou D., Salerno A., Strambo D., Livio F., Navi B.B., Michel P. Clinical and demographic characteristics, mechanisms, and outcomes in patients with acute ischemic stroke and newly diagnosed or known activecancer. Neurology, 2023; 100 (24): e2477‒e2489. doi: 10.1212/WNL.0000000000207341Costamagna G., Hottinger A., Milionis H., Lambrou D., Salerno A., Strambo D., Livio F., Navi B.B., Michel P. Clinical and demographic characteristics, mechanisms, and outcomes in patients with acute ischemic stroke and newly diagnosed or known activecancer. Neurology, 2023; 100 (24): e2477‒e2489. doi: 10.1212/WNL.0000000000207341Navi B.B., Reiner A.S., Kamel H., Iadecola C., Okin P.M., Elkind M.S.V., Panageas K.S., DeAngelis L.M. Risk of arterial thromboembolism in patients with cancer. J. Am. Coll. Cardiol., 2017; 70 (8): 926‒938. doi: 10.1016/j.jacc.2017.06.047Navi B.B., Reiner A.S., Kamel H., Iadecola C., Okin P.M., Elkind M.S.V., Panageas K.S., DeAngelis L.M. Risk of arterial thromboembolism in patients with cancer. J. Am. Coll. Cardiol., 2017; 70 (8): 926‒938. doi: 10.1016/j.jacc.2017.06.047Mulder F.I., Horváth-Puhó E., van Es N., Pedersen L., Büller H.R., Bøtker H.E., Sørensen H.T. Arterial thromboembolism in cancer patients: a danish population-based cohort study. JACC CardioOncol., 2021; 3 (2): 205‒218. doi: 10.1016/j.jaccao.2021.02.007Mulder F.I., Horváth-Puhó E., van Es N., Pedersen L., Büller H.R., Bøtker H.E., Sørensen H.T. Arterial thromboembolism in cancer patients: a danish population-based cohort study. JACC CardioOncol., 2021; 3 (2): 205‒218. doi: 10.1016/j.jaccao.2021.02.007Navi B.B., Reiner A.S., Kamel H., Iadecola C., Elkind M.S, Panageas K.S., DeAngelis L.M. Association between incident cancer and subsequent stroke. Ann. Neurol., 2015; 77 (2): 291‒300. doi: 10.1002/ana.24325Navi B.B., Reiner A.S., Kamel H., Iadecola C., Elkind M.S, Panageas K.S., DeAngelis L.M. Association between incident cancer and subsequent stroke. Ann. Neurol., 2015; 77 (2): 291‒300. doi: 10.1002/ana.24325Chen P.C., Muo C.H., Lee Y.T., Yu Y.H., Sung F.C. Lung cancer and incidence of stroke: a population-based cohort study. Stroke, 2011; 42 (11): 3034‒309. doi: 10.1161/STROKEAHA.111.615534Chen P.C., Muo C.H., Lee Y.T., Yu Y.H., Sung F.C. Lung cancer and incidence of stroke: a population-based cohort study. Stroke, 2011; 42 (11): 3034‒309. doi: 10.1161/STROKEAHA.111.615534Kuan A.S., Teng C.J., Wu H.H., Su V.Y., Chen Y.T., Chien S.H.., Yeh CM., Hu L.Y., Chen T.J., Tzeng C.H., Liu C.J. Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study. BMC Med., 2014; 12: 53. doi: 10.1186/1741-7015-12-53Kuan A.S., Teng C.J., Wu H.H., Su V.Y., Chen Y.T., Chien S.H.., Yeh CM., Hu L.Y., Chen T.J., Tzeng C.H., Liu C.J. Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study. BMC Med., 2014; 12: 53. doi: 10.1186/1741-7015-12-53Navi B.B., Singer S., Merkler A.E., Cheng N.T., Stone J.B., Kamel H., Iadecola C., Elkind M.S., DeAngelis L.M. Recurrent thromboembolic events after ischemic stroke in patients with cancer. Neurology, 2014; 83 (1): 26‒33. doi: 10.1212/WNL.0000000000000539Navi B.B., Singer S., Merkler A.E., Cheng N.T., Stone J.B., Kamel H., Iadecola C., Elkind M.S., DeAngelis L.M. Recurrent thromboembolic events after ischemic stroke in patients with cancer. Neurology, 2014; 83 (1): 26‒33. doi: 10.1212/WNL.0000000000000539Sonbol Y.T., Elgenidy A., Awad A.K., Elmehrath A.O., Kobeissi H., Afifi A.M., Ghozy S. Stroke as a cause of death in patients with cancer: a SEER-based study. J. Stroke Cerebrovasc. Dis., 2023; 32 (8): 107154. doi: 10.1016/j.jstrokecerebrovasdis.2023.107154Sonbol Y.T., Elgenidy A., Awad A.K., Elmehrath A.O., Kobeissi H., Afifi A.M., Ghozy S. Stroke as a cause of death in patients with cancer: a SEER-based study. J. Stroke Cerebrovasc. Dis., 2023; 32 (8): 107154. doi: 10.1016/j.jstrokecerebrovasdis.2023.107154Dittrich T.D., Aujesky M., Rudin S., Zietz A., Wagner B., Polymeris A., Altersberger V.L., Sinnecker T., Gensicke H., Engelter S.T., Lyrer P., Hess V., Sutter R., Nickel C.H., Bonati L.H., Fischer U., Psychogios M., Katan M., De Marchis G.M. Apical pulmonary lesions suspected of malignancy visible on neck CT angiography performed for acute stroke: Prevalence, treatment, and clinical implications ‒ the PLEURA study. Eur. Stroke J., 2023; 8 (2): 549‒556. doi: 10.1177/23969873231151488Dittrich T.D., Aujesky M., Rudin S., Zietz A., Wagner B., Polymeris A., Altersberger V.L., Sinnecker T., Gensicke H., Engelter S.T., Lyrer P., Hess V., Sutter R., Nickel C.H., Bonati L.H., Fischer U., Psychogios M., Katan M., De Marchis G.M. Apical pulmonary lesions suspected of malignancy visible on neck CT angiography performed for acute stroke: Prevalence, treatment, and clinical implications ‒ the PLEURA study. Eur. Stroke J., 2023; 8 (2): 549‒556. doi: 10.1177/23969873231151488Ha J., Lee M.J.., Kim S.J., Park B.Y., Park H., Cho S., Chung J.W., Seo W.K., Kim G.M., Bang O.Y., Chung C.S. Prevalence and impact of venous and arterial thromboembolism in patients with embolic stroke of undetermined source with or without active cancer. J. Am. Heart. Assoc., 2019; 8 (21): e013215. doi: 10.1161/JAHA.119.013215Ha J., Lee M.J.., Kim S.J., Park B.Y., Park H., Cho S., Chung J.W., Seo W.K., Kim G.M., Bang O.Y., Chung C.S. Prevalence and impact of venous and arterial thromboembolism in patients with embolic stroke of undetermined source with or without active cancer. J. Am. Heart. Assoc., 2019; 8 (21): e013215. doi: 10.1161/JAHA.119.013215Brenner B., Bikdeli B., Tzoran I., Madridano O., Lуpez-Reyes R., Suriñach J.M., Blanco-Molina Á., Tufano A., Núñez J.J.L., Trujillo-Santos J., Monreal M. RIETE Investigators. Arterial ischemic events are a major complication in cancer patients with venous thromboembolism. Am. J. Med., 2018; 131 (9): 1095‒1103. doi: 10.1016/j.amjmed.2018.04.037Brenner B., Bikdeli B., Tzoran I., Madridano O., Lуpez-Reyes R., Suriñach J.M., Blanco-Molina Á., Tufano A., Núñez J.J.L., Trujillo-Santos J., Monreal M. RIETE Investigators. Arterial ischemic events are a major complication in cancer patients with venous thromboembolism. Am. J. Med., 2018; 131 (9): 1095‒1103. doi: 10.1016/j.amjmed.2018.04.037Sun M.Y., Bhaskar S.M.M. bridging the gap in cancer-related stroke management: update on therapeutic and preventive approaches. Int. J. Mol. Sci., 2023; 24 (9): 7981. doi: 10.3390/ijms24097981Sun M.Y., Bhaskar S.M.M. bridging the gap in cancer-related stroke management: update on therapeutic and preventive approaches. Int. J. Mol. Sci., 2023; 24 (9): 7981. doi: 10.3390/ijms24097981Fitzpatrick T., Carrier M., Le Gal G. Cancer, atrial fibrillation, and stroke. Thromb. Res., 2017; 155: 101‒105. doi: 10.1016/j.thromres.2017.05.006Fitzpatrick T., Carrier M., Le Gal G. Cancer, atrial fibrillation, and stroke. Thromb. Res., 2017; 155: 101‒105. doi: 10.1016/j.thromres.2017.05.006Lun R., Roy D.C., Hao Y., Deka R., Huang W.K., Navi B.B., Siegal D.M., Ramsay T., Fergusson D., Shorr R., Dowlatshahi D. Incidence of stroke in the first year after diagnosis of cancer-A systematic review and meta-analysis. Front. Neurol., 2022; 13: 966190. doi: 10.3389/fneur.2022.966190Lun R., Roy D.C., Hao Y., Deka R., Huang W.K., Navi B.B., Siegal D.M., Ramsay T., Fergusson D., Shorr R., Dowlatshahi D. Incidence of stroke in the first year after diagnosis of cancer-A systematic review and meta-analysis. Front. Neurol., 2022; 13: 966190. doi: 10.3389/fneur.2022.966190Navi B.B., Kasner S.E., Elkind M.S.V., Cushman M., Bang O.Y., DeAngelis L.M. Cancer and embolic stroke of undetermined source. Stroke, 2021; 52 (3): 1121‒1130. doi: 10.1161/STROKEAHA.120.032002Navi B.B., Kasner S.E., Elkind M.S.V., Cushman M., Bang O.Y., DeAngelis L.M. Cancer and embolic stroke of undetermined source. Stroke, 2021; 52 (3): 1121‒1130. doi: 10.1161/STROKEAHA.120.032002Bamias A., Tzannis K., Zakopoulou R., Sakellakis M., Dimitriadis J., Papatheodoridi A., Rallidis L., Halvatsiotis P., Tsiara A., Kaparelou M., Kostouros E., Barbarousi D., Koutsoukos K., Fragiadis E., Dellis A.E., Anastasiou I., Stravodimos K., Pinitas A., Papatsoris A., Adamakis I., Varkarakis I., Fragoulis C., Pagoni S., Matsouka C., Skolarikos A., Mitropoulos D., Doumas K., Deliveliotis C., Constantinides C., Dimopoulos M.A. Risk for arterial thromboembolic events (ATEs) in patients with advanced urinary tract cancer (aUTC) treated with firstline chemotherapy: single-center, observational study. Curr. Oncol., 2022; 29 (9): 6077‒6090. doi: 10.3390/curroncol29090478Bamias A., Tzannis K., Zakopoulou R., Sakellakis M., Dimitriadis J., Papatheodoridi A., Rallidis L., Halvatsiotis P., Tsiara A., Kaparelou M., Kostouros E., Barbarousi D., Koutsoukos K., Fragiadis E., Dellis A.E., Anastasiou I., Stravodimos K., Pinitas A., Papatsoris A., Adamakis I., Varkarakis I., Fragoulis C., Pagoni S., Matsouka C., Skolarikos A., Mitropoulos D., Doumas K., Deliveliotis C., Constantinides C., Dimopoulos M.A. Risk for arterial thromboembolic events (ATEs) in patients with advanced urinary tract cancer (aUTC) treated with firstline chemotherapy: single-center, observational study. Curr. Oncol., 2022; 29 (9): 6077‒6090. doi: 10.3390/curroncol29090478Виценя М.В., Агеев Ф.Т., Гиляров М.Ю., Овчинников А.Г., Орлова Р.В., Полтавская М.Г., Сычева Е.А. Практические рекомендации по коррекции кардиоваскулярной токсичности противоопухолевой лекарственной терапии. Злокачественные опухоли, 2019: 9 (3S2): 609–627. doi: 10.18027/22245057-2019-9-3s2-609-627 [Vitsenya M.V., Ageev F.T., Gilyarov M.Yu., Ovchinnikov A.G., Orlova R.V., Poltavskaya M.G., Sycheva E.A. Practical recommendations for the correction of cardiovascular toxicity of antitumor drug therapy. Malignant tumors, 2019: 9 (3S2): 609–627. (In Russ.)]. doi: 10.18027/22245057-2019-9-3s2-609-627Виценя М.В., Агеев Ф.Т., Гиляров М.Ю., Овчинников А.Г., Орлова Р.В., Полтавская М.Г., Сычева Е.А. Практические рекомендации по коррекции кардиоваскулярной токсичности противоопухолевой лекарственной терапии. Злокачественные опухоли, 2019: 9 (3S2): 609–627. doi: 10.18027/22245057-2019-9-3s2-609-627 [Vitsenya M.V., Ageev F.T., Gilyarov M.Yu., Ovchinnikov A.G., Orlova R.V., Poltavskaya M.G., Sycheva E.A. Practical recommendations for the correction of cardiovascular toxicity of antitumor drug therapy. Malignant tumors, 2019: 9 (3S2): 609–627. (In Russ.)]. doi: 10.18027/22245057-2019-9-3s2-609-627Yhim H.Y., Lee J., Kim K.H., Kim S.A., Lee J.Y., Hwang H.G., Hong J., Lee J.O., Bang S.M. Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximabbased combination chemotherapy: A population-based study in Korea. Thromb. Res., 2023; 231: 50‒57. doi: 10.1016/j.thromres.2023.10.005Yhim H.Y., Lee J., Kim K.H., Kim S.A., Lee J.Y., Hwang H.G., Hong J., Lee J.O., Bang S.M. Increased risk of venous and arterial thromboembolism in patients with colorectal cancer receiving cetuximabbased combination chemotherapy: A population-based study in Korea. Thromb. Res., 2023; 231: 50‒57. doi: 10.1016/j.thromres.2023.10.005Kelly A., Toale C., Moloney M.A., Kavanagh E.G. Outcomes of acute limb ischaemia in patients with underlying malignancy: a systematic review. EJVES Vasc. Forum, 2021; 54: 13‒20. doi: 10.1016/j.ejvsvf.2021.10.019Kelly A., Toale C., Moloney M.A., Kavanagh E.G. Outcomes of acute limb ischaemia in patients with underlying malignancy: a systematic review. EJVES Vasc. Forum, 2021; 54: 13‒20. doi: 10.1016/j.ejvsvf.2021.10.019Sundbøll J., Veres K., Horváth-Puhó E., Adelborg K., Sørensen H.T. Risk and prognosis of cancer after lower limb arterial thrombosis. Circulation, 2018; 138 (7): 669‒677. doi: 10.1161/CIRCULATIONAHA.117.032617Sundbøll J., Veres K., Horváth-Puhó E., Adelborg K., Sørensen H.T. Risk and prognosis of cancer after lower limb arterial thrombosis. Circulation, 2018; 138 (7): 669‒677. doi: 10.1161/CIRCULATIONAHA.117.032617Valent P., Hadzijusufovic E., Schernthaner G.H., Wolf D., Rea D., le Coutre P. Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors. Blood, 2015; 125 (6): 901‒906. doi: 10.1182/blood-2014-09-594432Valent P., Hadzijusufovic E., Schernthaner G.H., Wolf D., Rea D., le Coutre P. Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors. Blood, 2015; 125 (6): 901‒906. doi: 10.1182/blood-2014-09-594432El Sakka K., Gambhir R.P.S., Halawa M., Chong P., Rashid H. Association of malignant disease with critical leg ischaemia. Br. J .Surg., 2005; 92: 1498–1501. doi:10.1002/bjs.5125El Sakka K., Gambhir R.P.S., Halawa M., Chong P., Rashid H. Association of malignant disease with critical leg ischaemia. Br. J .Surg., 2005; 92: 1498–1501. doi:10.1002/bjs.5125Tsang J.S., Naughton P.A., O’Donnell J., Wang T.T., Moneley D.S., Kelly C.J., Leahy A.L. Acute limb ischemia in cancer patients: should we surgically intervene? Ann. Vasc. Surg., 2011; 25 (7): 954‒960. doi: 10.1016/j.avsg.2011.06.002Tsang J.S., Naughton P.A., O’Donnell J., Wang T.T., Moneley D.S., Kelly C.J., Leahy A.L. Acute limb ischemia in cancer patients: should we surgically intervene? Ann. Vasc. Surg., 2011; 25 (7): 954‒960. doi: 10.1016/j.avsg.2011.06.002Larsen T.L., Brekke J., Garresori H., Frøen H., Jacobsen E.M., Torfoss D., Wik H.S., Enden T.R., Porojnicu A.C., Quist-Paulsen P., Velle E., Sandset P.M., Ree A.H., Dahm A.E.A. Arterial thromboembolism in cancer patients treated with apixaban. Blood, 2022; 140 (Supp. 1): 11366–11367. doi: 10.1182/ blood-2022-160363Larsen T.L., Brekke J., Garresori H., Frøen H., Jacobsen E.M., Torfoss D., Wik H.S., Enden T.R., Porojnicu A.C., Quist-Paulsen P., Velle E., Sandset P.M., Ree A.H., Dahm A.E.A. Arterial thromboembolism in cancer patients treated with apixaban. Blood, 2022; 140 (Supp. 1): 11366–11367. doi: 10.1182/ blood-2022-160363Lesterhuis W.J., van Spronsen D.J., Schultze-Kool L.J., de Mulder P.H. Acute arterial occlusion after chemotherapy for testicular cancer. Lancet Oncol., 2005; 6 (11): 910. doi: 10.1016/S1470-2045(05)70428-9Lesterhuis W.J., van Spronsen D.J., SchultzeKool L.J., de Mulder P.H. Acute arterial occlusion after chemotherapy for testicular cancer. Lancet Oncol., 2005; 6 (11): 910. doi: 10.1016/S1470-2045(05)70428-9Grilz E., Königsbrügge O., Posch F., Schmidinger M., Pirker R., Lang I.M., Pabinger I., Ay C. Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer. Haematologica, 2018; 103 (9): 1549‒1556. doi: 10.3324/haematol.2018.192419Grilz E., Königsbrügge O., Posch F., Schmidinger M., Pirker R., Lang I.M., Pabinger I., Ay C. Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer. Haematologica, 2018; 103 (9): 1549‒1556. doi: 10.3324/haematol.2018.192419Lapébie F.X., Aboyans V., Lacroix P., Constans J., Boulon C., Messas E., Ferrières J., Bongard V., Bura-Rivière A. Editor’s choice ‒ External applicability of the COMPASS and VOYAGER-PAD trials on patients with symptomatic lower extremity artery disease in France: The COPART registry. Eur. J. Vasc. Endovasc. Surg., 2021; 62 (3): 439‒449. doi: 10.1016/j.ejvs.2021.05.028Lapébie F.X., Aboyans V., Lacroix P., Constans J., Boulon C., Messas E., Ferrières J., Bongard V., BuraRivière A. Editor’s choice ‒ External applicability of the COMPASS and VOYAGER-PAD trials on patients with symptomatic lower extremity artery disease in France: The COPART registry. Eur. J. Vasc. Endovasc. Surg., 2021; 62 (3): 439‒449. doi: 10.1016/j.ejvs.2021.05.028Nicolajsen C.W., Dickenson M.H., Budtz-Lilly J., Eldrup N. Frequency of cancer in patients operated on for acute peripheral arterial thrombosis and the impact on prognosis. J. Vasc. Surg., 2015; 62 (6): 1598‒1606. doi: 10.1016/j.jvs.2015.06.223Nicolajsen C.W., Dickenson M.H., Budtz-Lilly J., Eldrup N. Frequency of cancer in patients operated on for acute peripheral arterial thrombosis and the impact on prognosis. J. Vasc. Surg., 2015; 62 (6): 1598‒1606. doi: 10.1016/j.jvs.2015.06.223Govsyeyev N., Malgor R.D., Hoffman C., Harroun N., Sturman E., Al-Musawi M., Malgor E.A., Jacobs D.L., Nehler M. A systematic review and meta-analysis of outcomes after acute limb ischemia in patients with cancer. J. Vasc. Surg., 2021; 74 (3): 1033‒1040.e1. doi: 10.1016/j.jvs.2021.03.058Govsyeyev N., Malgor R.D., Hoffman C., Harroun N., Sturman E., Al-Musawi M., Malgor E.A., Jacobs D.L., Nehler M. A systematic review and meta-analysis of outcomes after acute limb ischemia in patients with cancer. J. Vasc. Surg., 2021; 74 (3): 1033‒1040.e1. doi: 10.1016/j.jvs.2021.03.058Javid M., Magee T.R., Galland R.B. Arterial thrombosis associated with malignant disease. Eur. J. Vasc. Endovasc. Surg., 2008; 35 (1): 84‒87. doi: 10.1016/j.ejvs.2007.08.014Javid M., Magee T.R., Galland R.B. Arterial thrombosis associated with malignant disease. Eur. J. Vasc. Endovasc. Surg., 2008; 35 (1): 84‒87. doi: 10.1016/j.ejvs.2007.08.014Morris-Stiff G., Lewis M.H. Surgical treatment of acute limb ischaemia in the presence of malignancy. Int. J. Surg., 2010; 8 (3): 233‒235. doi: 10.1016/j.ijsu.2010.01.007Morris-Stiff G., Lewis M.H. Surgical treatment of acute limb ischaemia in the presence of malignancy. Int. J. Surg., 2010; 8 (3): 233‒235. doi: 10.1016/j.ijsu.2010.01.007Pernod G., Cohen A., Mismetti P., Sanchez O., Mahé I. INNOVTE CAT Working Group. Cancerrelated arterial thromboembolic events. Arch. Cardiovasc. Dis., 2024; 117 (1): 101‒113. doi: 10.1016/j.acvd.2023.11.007Pernod G., Cohen A., Mismetti P., Sanchez O., Mahé I. INNOVTE CAT Working Group. Cancerrelated arterial thromboembolic events. Arch. Cardiovasc. Dis., 2024; 117 (1): 101‒113. doi: 10.1016/j.acvd.2023.11.007Liu Y., Wang J., Guo L., Ping L. Risk factors of embolism for the cardiac myxoma patients: a systematic review and metanalysis. BMC Cardiovasc. Disord., 2020; 20 (1): 348. doi: 10.1186/s12872-02001631-wLiu Y., Wang J., Guo L., Ping L. Risk factors of embolism for the cardiac myxoma patients: a systematic review and metanalysis. BMC Cardiovasc. Disord., 2020; 20 (1): 348. doi: 10.1186/s12872-02001631-wChandler C. Malignant arterial tumor embolization. J. Surg. Oncol., 1993; 52 (3): 197‒202. doi: 10.1002/jso.2930520317Chandler C. Malignant arterial tumor embolization. J. Surg. Oncol., 1993; 52 (3): 197‒202. doi: 10.1002/jso.2930520317Hussain S.M.A. Tumor embolism and acute arterial occlusion: A systematic review. Surgery Open Science, 2022; 10: 216–222. doi.org/10.1016/j. sopen.2022.10.006Hussain S.M.A. Tumor embolism and acute arterial occlusion: A systematic review. Surgery Open Science, 2022; 10: 216–222. doi.org/10.1016/j. sopen.2022.10.006Qin Y., Zhang L., Liang X., Sun X., Wang N., Yuan M., Wang Q., Wu D. Venous and arterial thromboembolism in patients with metastatic lung cancer. Clin. Appl. Thromb. Hemost., 2023; 29: 10760296231159121. doi: 10.1177/10760296231159121Qin Y., Zhang L., Liang X., Sun X., Wang N., Yuan M., Wang Q., Wu D. Venous and arterial thromboembolism in patients with metastatic lung cancer. Clin. Appl. Thromb. Hemost., 2023; 29: 10760296231159121. doi: 10.1177/10760296231159121Mitrovic M., Pantic N., Sabljic N., Bukumiric Z., Virijevic M., Pravdic Z., Cvetkovic M., Rajic J., Bodrozic J., Milosevic V., Todorovic-Balint M., Vidovic A., Suvajdzic-Vukovic N., Antic D. Arterial thrombosis in patients with acute myeloid leukemia: incidence and risk factors. Cancers (Basel), 2023; 15 (11): 3060. doi: 10.3390/cancers15113060Mitrovic M., Pantic N., Sabljic N., Bukumiric Z., Virijevic M., Pravdic Z., Cvetkovic M., Rajic J., Bodrozic J., Milosevic V., Todorovic-Balint M., Vidovic A., Suvajdzic-Vukovic N., Antic D. Arterial thrombosis in patients with acute myeloid leukemia: incidence and risk factors. Cancers (Basel), 2023; 15 (11): 3060. doi: 10.3390/cancers15113060Akabane K., Watanabe T., Tajima Y., Toyama S., Tamate Y., Uchida T. Case Report: Acute arterial occlusion of the right lower extremity due to left atrial invasion from pulmonary metastases of thyroid cancer. Front. Cardiovasc. Med., 2023; 10: 1221180. doi: 10.3389/fcvm.2023.1221180Akabane K., Watanabe T., Tajima Y., Toyama S., Tamate Y., Uchida T. Case Report: Acute arterial occlusion of the right lower extremity due to left atrial invasion from pulmonary metastases of thyroid cancer. Front. Cardiovasc. Med., 2023; 10: 1221180. doi: 10.3389/fcvm.2023.1221180Abraham K.P., Reddy V., Gattuso P. Neoplasms metastatic to the heart: review of 3314 consecutive autopsies. Am. J. Cardiovasc. Pathol., 1990; 3 (3): 195‒198.Abraham K.P., Reddy V., Gattuso P. Neoplasms metastatic to the heart: review of 3314 consecutive autopsies. Am. J. Cardiovasc. Pathol., 1990; 3 (3): 195‒198.Klatt E.C., Heitz D.R. Cardiac metastases. Cancer, 1990; 65 (6): 1456‒1459. doi: 10.1002/1097-0142(19900315)65:6<1456::aidcncr2820650634>3.0.co;2-5Klatt E.C., Heitz D.R. Cardiac metastases. Cancer, 1990; 65 (6): 1456‒1459. doi: 10.1002/1097-0142(19900315)65:6<1456::aidcncr2820650634>3.0.co;2-5Kaschwich M., Peters F., Hischke S., Rieß H.C., Gansel M., Marschall U., L’Hoest H., Heidemann F., Debus E.S., Acar L., Kreutzburg T., Behrendt C.A. Long-term incidence of cancer after index treatment for symptomatic peripheral arterial disease ‒ a health insurance claims data analysis. Vasa, 2020; 49 (6): 493‒499. doi: 10.1024/0301-1526/a000901Kaschwich M., Peters F., Hischke S., Rieß H.C., Gansel M., Marschall U., L’Hoest H., Heidemann F., Debus E.S., Acar L., Kreutzburg T., Behrendt C.A. Long-term incidence of cancer after index treatment for symptomatic peripheral arterial disease ‒ a health insurance claims data analysis. Vasa, 2020; 49 (6): 493‒499. doi: 10.1024/0301-1526/a000901Navi B.B., Reiner A.S., Kamel H., Iadecola C., Elkind M.S., Panageas K.S., DeAngelis L.M. OC-02 ‒ Risk of arterial thromboembolism in patients with breast cancer. Thromb. Res., 2016; 140 Suppl 1: S169. doi: 10.1016/S0049-3848(16)30119-0Navi B.B., Reiner A.S., Kamel H., Iadecola C., Elkind M.S., Panageas K.S., DeAngelis L.M. OC-02 ‒ Risk of arterial thromboembolism in patients with breast cancer. Thromb. Res., 2016; 140 Suppl 1: S169. doi: 10.1016/S0049-3848(16)30119-0González Rodríguez P., Gisbert S.M.M., Chiriboga Granja J.I., Medina M.C., Palonés F.J.G. Anaplastic thyroid tumor as an embolic source of metastasis. J. Vasc. Surg. Cases Innov. Tech., 2022; 8 (3): 386‒389. doi: 10.1016/j.jvscit.2022.05.006González Rodríguez P., Gisbert S.M.M., Chiriboga Granja J.I., Medina M.C., Palonés F.J.G. Anaplastic thyroid tumor as an embolic source of metastasis. J. Vasc. Surg. Cases Innov. Tech., 2022; 8 (3): 386‒389. doi: 10.1016/j.jvscit.2022.05.006Lioudaki S., Kontopodis N., Palioudakis S., Koutsopoulos A.V., Drositis I., Ioannou C.V. Acute aortic occlusion due to tumor embolism in a patient with lung malignancy. SAGE Open Med. Case Rep., 2017; 5: 2050313X17720627. doi: 10.1177/2050313X17720627Lioudaki S., Kontopodis N., Palioudakis S., Koutsopoulos A.V., Drositis I., Ioannou C.V. Acute aortic occlusion due to tumor embolism in a patient with lung malignancy. SAGE Open Med. Case Rep., 2017; 5: 2050313X17720627. doi: 10.1177/2050313X17720627Almatari A.L., Sathe A., Wideman L., Dewan C.A., Vaughan J.P., Bennie I.C., Buscarini M. Renal cell carcinoma with tumor thrombus: A review of relevant anatomy and surgical techniques for the general urologist. Urol. Oncol., 2023; 41 (4): 153‒165. doi: 10.1016/j.urolonc.2022.11.021Almatari A.L., Sathe A., Wideman L., Dewan C.A., Vaughan J.P., Bennie I.C., Buscarini M. Renal cell carcinoma with tumor thrombus: A review of relevant anatomy and surgical techniques for the general urologist. Urol. Oncol., 2023; 41 (4): 153‒165. doi: 10.1016/j.urolonc.2022.11.021Sadat U., Noor N., See T.C., Varty K. Peripheral arterial ischemia by a primary lung tumour invading left atrium. Lung Cancer, 2007; 57 (2): 237‒239. doi: 10.1016/j.lungcan.2007.02.001Sadat U., Noor N., See T.C., Varty K. Peripheral arterial ischemia by a primary lung tumour invading left atrium. Lung Cancer, 2007; 57 (2): 237‒239. doi: 10.1016/j.lungcan.2007.02.001Navi B.B., Reiner A.S., Kamel H., Iadecola C., Okin P.M., Tagawa S.T., Panageas K.S., DeAngelis L.M. Arterial thromboembolic events preceding the diagnosis of cancer in older persons. Blood, 2019; 133 (8): 781‒789. doi: 10.1182/blood-2018-06-860874Navi B.B., Reiner A.S., Kamel H., Iadecola C., Okin P.M., Tagawa S.T., Panageas K.S., DeAngelis L.M. Arterial thromboembolic events preceding the diagnosis of cancer in older persons. Blood, 2019; 133 (8): 781‒789. doi: 10.1182/blood-2018-06-860874Yu J., Li A., Laureano M., Crowther M. Frequency of arterial thromboembolism in populations with malignancies: A systematic review. Thromb. Res., 2019; 184: 16‒23. doi: 10.1016/j.thromres.2019.10.004Yu J., Li A., Laureano M., Crowther M. Frequency of arterial thromboembolism in populations with malignancies: A systematic review. Thromb. Res., 2019; 184: 16‒23. doi: 10.1016/j.thromres.2019.10.004Vavlukis M., Kotlar I., Chaparoska E., Antova E., Kedev S. Diffuse arterial thrombosis as a first manifestation of occult malignancy. Case Rep. Med., 2016; 2016: 1658392. doi: 10.1155/2016/1658392Vavlukis M., Kotlar I., Chaparoska E., Antova E., Kedev S. Diffuse arterial thrombosis as a first manifestation of occult malignancy. Case Rep. Med., 2016; 2016: 1658392. doi: 10.1155/2016/1658392Palumbo A., Cavo M., Bringhen S., Zamagni E., Romano A., Patriarca F., Rossi D., Gentilini F., Crippa C., Galli M., Nozzoli C., Ria R., Marasca R., Montefusco V., Baldini L., Elice F., Callea V., Pulini S., Carella A.M., Zambello R., Benevolo G., Magarotto V., Tacchetti P., Pescosta N., Cellini C., Polloni C., Evangelista A., Caravita T., Morabito F., Offidani M., Tosi P., Boccadoro M. Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial. J. Clin. Oncol., 2011; 29 (8): 986‒993. doi: 10.1200/JCO.2010.31.6844Palumbo A., Cavo M., Bringhen S., Zamagni E., Romano A., Patriarca F., Rossi D., Gentilini F., Crippa C., Galli M., Nozzoli C., Ria R., Marasca R., Montefusco V., Baldini L., Elice F., Callea V., Pulini S., Carella A.M., Zambello R., Benevolo G., Magarotto V., Tacchetti P., Pescosta N., Cellini C., Polloni C., Evangelista A., Caravita T., Morabito F., Offidani M., Tosi P., Boccadoro M. Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial. J. Clin. Oncol., 2011; 29 (8): 986‒993. doi: 10.1200/JCO.2010.31.6844Landolfi R., Marchioli R., Kutti J., Gisslinger H., Tognoni G., Patrono C., Barbui T. European Collaboration on Low-Dose Aspirin in Polycythemia Vera Investigators. Efficacy and safety of low-dose aspirin in polycythemia vera. N. Engl. J. Med., 2004; 350 (2): 114‒124. doi: 10.1056/NEJMoa035572Landolfi R., Marchioli R., Kutti J., Gisslinger H., Tognoni G., Patrono C., Barbui T. European Collaboration on Low-Dose Aspirin in Polycythemia Vera Investigators. Efficacy and safety of low-dose aspirin in polycythemia vera. N. Engl. J. Med., 2004; 350 (2): 114‒124. doi: 10.1056/NEJMoa035572Xu Y., Mallity C., Collins E., Siegal D.M., Wang T.F., Carrier M. Anticoagulation for the prevention of arterial thromboembolism in cancer patients by primary tumor site: a systematic review and meta-analysis of randomized trials. Eur. Heart J. Cardiovasc. Pharmacother., 2025; 10 (8): 665‒675. doi: 10.1093/ehjcvp/pvae068Xu Y., Mallity C., Collins E., Siegal D.M., Wang T.F., Carrier M. Anticoagulation for the prevention of arterial thromboembolism in cancer patients by primary tumor site: a systematic review and meta-analysis of randomized trials. Eur. Heart J. Cardiovasc. Pharmacother., 2025; 10 (8): 665‒675. doi: 10.1093/ehjcvp/pvae068Xu Y., Cole K., Collins E., Moledina A., Mallity C., Carrier M. Anticoagulation for the prevention of arterial thrombosis in ambulatory cancer patients: systematic review and meta-analysis. JACC CardioOncol., 2023; 5 (4): 520‒532. doi: 10.1016/j.jaccao.2023.04.003Xu Y., Cole K., Collins E., Moledina A., Mallity C., Carrier M. Anticoagulation for the prevention of arterial thrombosis in ambulatory cancer patients: systematic review and meta-analysis. JACC CardioOncol., 2023; 5 (4): 520‒532. doi: 10.1016/j.jaccao.2023.04.003Lyon A.R., López-Fernández T., Couch L.S., Asteggiano R., Aznar M.C., Bergler-Klein J., Boriani G., Cardinale D., Cordoba R., Cosyns B., Cutter D.J., de Azambuja E., de Boer R.A., Dent S.F., Farmakis D., Gevaert S.A., Gorog D.A., Herrmann J., Lenihan D., Moslehi J., Moura B., Salinger S.S., Stephens R., Suter T.M., Szmit S., Tamargo J., Thavendiranathan P., Tocchetti C.G., van der Meer P., van der Pal H.J.H. ESC Scientific Document Group. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur. Heart. J., 2022; 43 (41): 4229‒4361. doi: 10.1093/eurheartj/ehac244Lyon A.R., López-Fernández T., Couch L.S., Asteggiano R., Aznar M.C., Bergler-Klein J., Boriani G., Cardinale D., Cordoba R., Cosyns B., Cutter D.J., de Azambuja E., de Boer R.A., Dent S.F., Farmakis D., Gevaert S.A., Gorog D.A., Herrmann J., Lenihan D., Moslehi J., Moura B., Salinger S.S., Stephens R., Suter T.M., Szmit S., Tamargo J., Thavendiranathan P., Tocchetti C.G., van der Meer P., van der Pal H.J.H. ESC Scientific Document Group. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur. Heart. J., 2022; 43 (41): 4229‒4361. doi: 10.1093/eurheartj/ehac244Gevaert S.A., Halvorsen S., Sinnaeve P.R., Sambola A., Gulati G., Lancellotti P., van der Meer P., Lyon A.R., Farmakis D., Lee G., Boriani G., Wechalekar A., Okines A., Asteggiano R. Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases. Eur. Heart J. Acute Cardiovasc. Care, 2021; 10 (8): 947‒959. doi: 10.1093/ehjacc/zuab056Gevaert S.A., Halvorsen S., Sinnaeve P.R., Sambola A., Gulati G., Lancellotti P., van der Meer P., Lyon A.R., Farmakis D., Lee G., Boriani G., Wechalekar A., Okines A., Asteggiano R. Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases. Eur. Heart J. Acute Cardiovasc. Care, 2021; 10 (8): 947‒959. doi: 10.1093/ehjacc/zuab056Harnarayan P., Islam S., Naraynsingh V. Arterial embolism in malignancy: the role of surgery. Ther. Clin. Risk Manag., 2021; 17: 635‒640. doi: 10.2147/TCRM.S308026Harnarayan P., Islam S., Naraynsingh V. Arterial embolism in malignancy: the role of surgery. Ther. Clin. Risk Manag., 2021; 17: 635‒640. doi: 10.2147/TCRM.S308026Hussain S.M.A. Lung cancer embolization causing acute limb ischemia: a case report. J. Med. Case Rep., 2023; 17 (1): 56. doi: 10.1186/s13256-023-03769-5Hussain S.M.A. Lung cancer embolization causing acute limb ischemia: a case report. J. Med. Case Rep., 2023; 17 (1): 56. doi: 10.1186/s13256-023-03769-5Sato A., Matsumoto A., Naruse S., Isono Y., Maeda Y., Yamada M., Ikeda T., Sasajima Y., Jinno H. Acute arterial occlusive disease due to tumor thrombus from lung metastasis of breast cancer with cartilaginous and osseous metaplasia: a case report. Surg. Case Rep., 2023; 9 (1): 13. doi: 10.1186/s40792023-01598-8Sato A., Matsumoto A., Naruse S., Isono Y., Maeda Y., Yamada M., Ikeda T., Sasajima Y., Jinno H. Acute arterial occlusive disease due to tumor thrombus from lung metastasis of breast cancer with cartilaginous and osseous metaplasia: a case report. Surg. Case Rep., 2023; 9 (1): 13. doi: 10.1186/s40792023-01598-8Tsubouchi K., Ibusuki R., Makisumi K., Okamoto H., Iwasaki T., Okamatsu Y., Inoue K., Harada T. Tumor embolism as a cause of renal artery occlusion and acute Kidney injury diagnosed and treated with endovascular intervention in a patient with mediastinal undifferentiated sarcoma. Intern. Med., 2021; 60 (12): 1907‒1910. doi: 10.2169/internalmedicine.6249-20Tsubouchi K., Ibusuki R., Makisumi K., Okamoto H., Iwasaki T., Okamatsu Y., Inoue K., Harada T. Tumor embolism as a cause of renal artery occlusion and acute Kidney injury diagnosed and treated with endovascular intervention in a patient with mediastinal undifferentiated sarcoma. Intern. Med., 2021; 60 (12): 1907‒1910. doi: 10.2169/internalmedicine.6249-20Aboyans V., Ricco J.B., Bartelink M.E.L., Björck M., Brodmann M., Cohnert T., Collet J.P., Czerny M., de Carlo M., Debus S., Espinola-Klein C., Kahan T., Kownator S., Mazzolai L., Naylor A.R., Roffi M., Röther J., Sprynger M., Tendera M., Tepe G., Venermo M., Vlachopoulos C., Desormais I. ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO). The task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur. Heart J., 2018; 39 (9): 763‒816. doi: 10.1093/eurheartj/ehx095Aboyans V., Ricco J.B., Bartelink M.E.L., Björck M., Brodmann M., Cohnert T., Collet J.P., Czerny M., de Carlo M., Debus S., Espinola-Klein C., Kahan T., Kownator S., Mazzolai L., Naylor A.R., Roffi M., Röther J., Sprynger M., Tendera M., Tepe G., Venermo M., Vlachopoulos C., Desormais I. ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO). The task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur. Heart J., 2018; 39 (9): 763‒816. doi: 10.1093/eurheartj/ehx095

The authors declare that there are no conflicts of interest present.